Phoenix Biotech Acquisiti...

NASDAQ: PBAX · Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM

Phoenix Biotech Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-7.29M -667.74K -315.55K
Depreciation & Amortization
1.12M n/a n/a
Stock-Based Compensation
96.9K n/a n/a
Other Working Capital
n/a 773.67K -365.08K
Other Non-Cash Items
n/a -2.84M -16.48K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
n/a 2.41M -365.08K
Operating Cash Flow
-5.79M -1.09M -697.11K
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a -178.5M
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a 180.84M n/a
Investing Cash Flow
n/a 180.84M -178.5M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a -139.35M n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
571.68K -138.7M 180.3M
Financial Cash Flow
571.68K -138.7M 180.3M
Net Cash Flow
-5.22M 41.04M 1.1M
Free Cash Flow
-5.79M -1.09M -697.11K